Homeopathy 2009; 98(01): 56-59
DOI: 10.1016/j.homp.2008.11.009
Copyright © The Faculty of Homeopathy 2008

Treatment of spasmodic dysphonia with homeopathic medicine: a clinical case report

Steve An Xue
1   Speech Science Lab, Division of Speech and Hearing Sciences, 5th Floor, Prince Philips Dental Hospital, 34 Hospital Road, The University of Hong Kong, Hong Kong
Luc de Schepper
2   Renaissance Institute of Classical Homeopathy, United States
Grace Jianping Hao
1   Speech Science Lab, Division of Speech and Hearing Sciences, 5th Floor, Prince Philips Dental Hospital, 34 Hospital Road, The University of Hong Kong, Hong Kong
3   North Carolina Central University, United States
› Author Affiliations

Subject Editor:
Further Information

Publication History

Received29 May 2008
revised20 October 2008

accepted18 November 2008

Publication Date:
20 December 2017 (online)

Botulinum toxin (Botox) injection is the only conventional medical treatment available for patients with spasmodic dysphonia (SD). Some patients are reluctant to receive Botox treatment due to concerns about unknown long-term side effects, expense, and dependence on repeated injections. The purpose of the study was to report the perceptual and physiological changes in the vocal functions of an SD patient treated with classical homeopathy. The results were similar to a previous case report: classical homeopathy seems to be capable of amelioratiny SD symptoms beyond the short-term effects of Botox injections. Although the physiological mechanism of homeopathic healing is not fully accounted for by the current bio-medical models, it may be an effective therapeutic alternative for some SD patients.

  • References

  • 1 Blitzer A., Brin M.F., Steward C. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998; 108: 1435-1441.
  • 2 Aronson A.E., Lagerlund T.D. Neuroimaging studies do not prove the existence of brain abnormalities in spastic (Spasmodic) dysphonia. J Speech Hear Res 1991; 34: 801-811.
  • 3 Barkmeier J.M., Case J.L., Ludlow C.L. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges. J Commun Disord 2001; 34: 21-37.
  • 4 Bielamowicz S., Ludlow C.L. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia. Ann Otol Rhinol Laryngol 2000; 109: 194-203.
  • 5 Ludlow C.L., Naunton R.F., Sedory S.E., Schulz G.M., Hallet M. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology 1988; 38: 1220-1225.
  • 6 Ali S.O., Thomassen M., Schulz G. et al. Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215 O Pet study. J Speech Hear Res 2006; 49: 1127-1146.
  • 7 Boutsen F., Cannito M.P., Taylor M., Bender B. Botox treatment in adductor spasmodic dysphonia: a meta-analysis. J Speech Hear Res 2002; 45: 469-481.
  • 8 Duffy J.R., Yorkston K.M. Medical interventions for spasmodic dysphonia and some related conditions. A systematic review. J Med Speech Lang Pathol 2003; 11: ix-lviii.
  • 9 Ludlow C.L., Naunton R.F., Terada S., Anderson B.J. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection. Otolaryngol Head Neck Surg 1991; 104: 849-855.
  • 10 Whurr R., Lorch M., Lindsay M., Brookes G., Marsden C. Psychological function in spasmodic dysphonia before and after treatment with botulinum toxin. J Med Speech Lang Pathol 1998; 2: 81-91.
  • 11 Watts C., Whurr R. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review. Clin Rehabil 2006; 20: 112-122.
  • 12 Anari S., Carding P.N., Hawthorne M.R., Deakin J., Drinnan M.J. Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia. Laryngoscope 2007; 117 (10) 1888-1892.
  • 13 Berke G.S., Blackwell K.E., Gerratt B.R., Verneil A., Jackson K.S., Sercarz J.A. Selective laryngeal adductor denervation–reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999; 108 (03) 222-227.
  • 14 Blitzer A., Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 2001; 111: 218-226.
  • 15 Dedo H.H. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976; 85: 451-459.
  • 16 Ludlow C.L. Pathophysiology of the spasmodic dysphonias. Bell-Berti F., Raphael L.J. Producing speech: contemporary issues for Katherine Safford Harris. 1995. Woodbury, NY: American Institute of Physics; 291-308.
  • 17 Finitzo T., Freeman F. Spasmodic dysphonia, whether and where: results of seven years of research. J Speech Hear Res 1989; 32: 541-555.
  • 18 Simonyan K., Tovar-Moll F., Ostuni J. et al. Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain 2008; 131 (02) 447-459.
  • 19 de Schepper L. Hahnemann revisited. Santa Fe: Full of Life; 2001.
  • 20 Xue S., Hao J.G., de Schepper L. Homeopathic treatment of spasmodic dysphonia: a preliminary clinical experimentation. J Natl Soc Allied Health 2008; 5 (06) 1-8.
  • 21 Crevier-Buchman C., Laccoureye O., Papon J.F., Nurit D., Brasnu D. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture. J Voice 1997; 11 (02) 232-237.
  • 22 Lee L., Daughton S., Scheer S. et al. Use of acupuncture for the treatment of adductor spasmodic dysphonia: a preliminary investigation. J Voice 2003; 17 (03) 411-424.
  • 23 Edgar J.D., Sapienza C.M., Bidus K., Ludlow C.L. Acoustic measures of symptoms in abductor spasmodic dysphonia. J Voice 2001; 5 (03) 362-373.
  • 24 Nash E.A., Ludlow C.L. Laryngeal muscle activity during speech breaks in adductor spasmodic dysphonia. Laryngoscope 1996; 106: 484-489.
  • 25 Chapman E.H., Wilson J.J. Homeopathy in rehabilitation medicine. Compl Therapies in Phys Med and Rehab 1999; 10 (03) 705-727.